UNOMR AG

Building single biomolecule sensors for medical research.

UNOMR, a TechBio startup from ETH Zurich, is pioneering single-molecule protein modification analysis through their innovative serial nanopore sensor, currently focusing on protein glycosylation. Addressing a US$ 60B market, their patented solution has far-reaching applications across healthcare, pharmaceutical development, and food science, offering unprecedented insights into proteins for therapeutic discovery and medical food innovation. Driven by the vision of bringing advanced proteomics directly to the patient, UNOMR aims to catalyze the next breakthrough in precision medicine by making sophisticated protein analysis accessible.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

14.04.2025

UNOMR gets CHF 150,000 from Venture Kick to bring a new dimension to proteomics analysis (venturekick.ch)

15.02.2025

Innobooster funding

16.12.2024

Innosuisse funding received

01.04.2024

Bridge PoC funding received

No Jobs

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (150'000) 2025

Website